A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN) : A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients With Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

This is a study with 2 parts. Part 1 comprises a visit to collect biological samples necessary for the molecular characterization of chronic kidney disease. Part 2 comprises an observational period of 5 visits over a period up to 8 weeks. During Part 2, baseline tests will be conducted, and urine will be collected approximately every 2 weeks for 8 weeks. Patients may participate in Part 1, Part 2, or both, and will be followed for up to 1 year consisting of data collection from the patient's medical records and home collection of urine samples every 4 months..

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

ClinicalTrials.gov - (2021) vom: 20. Juli Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Diabetic Nephropathies
Glomerulosclerosis, Focal Segmental
Kidney Diseases
Medical Condition: Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Diabetic Nephropathies
Nephrosis, Lipoid
Recruitment Status: Terminated
Study Type: Observational

Anmerkungen:

Source: Link to the current ClinicalTrials.gov record., First posted: January 22, 2020, Last downloaded: ClinicalTrials.gov processed this data on August 02, 2021, Last updated: August 04, 2021

Study ID:

NCT04235621
GFB-887-501

Veröffentlichungen zur Studie:

fisyears:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG003274586